Pacritinib is a selective JAK2 and FLT3 kinase inhibitor used in the treatment of myelofibrosis and certain hematologic malignancies. It works by inhibiting signaling pathways that drive abnormal cell proliferation. Pacritinib API is manufactured under GMP-compliant conditions and is suitable for oral solid dosage formulations, including tablets.

Pacritinib API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.